The page lists 31 projects related to the topic "atherosclerosis".
# | |||
---|---|---|---|
1 | LARP4MOT | Structural and functional studies of LARP4, a new RNA binding protein involved in mRNA stabilisation and cell migration | 2016 |
2 | jamclay | Chemical Tools to Probe the Role of Bromodomains in the Parasite Trypanosoma cruzi | 2016 |
3 | ISPADMEC | Integrin specificity in rigidity sensitive proliferation, activation and directional migration of endothelial cells | 2015 |
4 | Athero MPh proliferation | Macrophage proliferation and ontogeny in murine models of atherosclerosis | 2016 |
5 | NanoMATe | Nanoparticles for Molecular Imaging of Atherosclerosis: from Diagnosis to Treatment | 2015 |
6 | AnandaCor | Concept and feasibility assessment for AnandaCor, a fast melting tablet, as a diagnostic device in ischemic heart conditions. | 2015 |
7 | FibreRemodel | Frontier research in arterial fibre remodelling for vascular disease diagnosis and tissue engineering | 2015 |
8 | MOGLYNET | Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study | 2015 |
9 | Angiolnc | Endothelial long non-coding RNAs | 2016 |
10 | SPCCT | In Vivo Spectral Photon Counting CT Molecular Imaging in Cardio- and Neuro-Vascular Diseases | 2016 |
11 | MONOCLE | A novel enhancer deletion strategy to determine non-classical monocyte function in atherosclerosis | 2017 |
12 | PROVASC | Cell-specific vascular protection by CXCL12/CXCR4 | 2016 |
13 | FAT NKT | Targeting iNKT cell and adipocyte crosstalk for control of metabolism and body weight | 2016 |
14 | CD40-INN | CD40 goes innate: defining and targeting CD40 signaling intermediates in the macrophage to treat atherosclerosis | 2016 |
15 | PROGLUTASIS | Protection of cardiometabolic inflammation by modulation of myeloid glutamine homeostasis | 2017 |
16 | LD_Biogenesis | Identification and characterization of sites of lipid droplet biogenesis in the ER | 2018 |
17 | MODVASC | Endothelial RNA Modifications in Vascular Homeostasis and Disease | 2018 |
18 | STRATO | Stress as a modifier of atherosclerosis - Novel mechanistic insights and therapeutic avenues - | 2018 |
19 | Striking streaks | Invariant Natural Killer T-cells in atherogenesis | 2018 |
20 | EpiBigDatainWomen | Epigenetic Data Integrated in a Big Data Approach to Unravel Novel Pathzays of CV Risk independent of classical CVD Risk Factors in Women. | 2019 |
21 | TICARDIO | Thrombo-inflammation in cardiovascular disease | 2019 |
22 | EDCMET | Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways | 2019 |
23 | GUTSY | The gut microbiota and its systemic effects on metabolism and atherosclerotic disease | 2019 |
24 | RGD-Diabetes | Development of RGD-therapeutics for cardio-metabolic disease | 2019 |
25 | IMPACT | Immune Mechanisms of Necrotic DNA Phagocytosis by Neutrophils: A Role for Integrins | 2020 |
26 | AstaFerm | A natural and high quality ingredient for dietary supplement derived from yeast fermentation to reduce oxidative stress and promote health and wellbeing | 2019 |
27 | TRACER | TRAF-STOP therapy to reduCe inflammation in athERosclerosis. | 2020 |
28 | ANIMATE | Adaptive Immunity in Human Atherosclerosis: Understanding its Cellular Basis to Define Novel Immunomodulatory Therapies | 2020 |
29 | LONGITOOLS | Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases | 2020 |
30 | EXPLOSIA | EXpansion and Phenotype Loss Of SMCs In Atherosclerosis: Causal effects and therapeutic possibilities | 2020 |
31 | MacrophageEGR | Egr1 and Egr2 regulate opposite transcriptional programs in macrophages | 2021 |